Evidence map›Paper›PMID 39937336›Full record

ReviewCerebellum (London, England)2025

Cerebellar Neuromodulation in Autism Spectrum Disorders and Social Cognition: Insights from Animal and Human Studies.

Yannis Elandaloussi, Océane Dufrenne, Aline Lefebvre, Josselin Houenou, Suhan Senova, Charles Laidi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yannis ElandaloussiChild and Adolescent Psychiatry Department, Robert Debre Hospital, APHP, 48 Boulevard Serrurier, Paris, France. yannis.elandaloussi@aphp.fr.
Océane DufrenneUniversité Paris Cité, Paris, France.
Aline LefebvreCEA, Université Paris-Saclay, Neurospin, Gif-sur-Yvette, France.
Josselin HouenouCEA, Université Paris-Saclay, Neurospin, Gif-sur-Yvette, France.
Suhan SenovaIMRB, Translational Neuro-Psychiatry, Univ Paris Est Créteil, INSERM U955, Créteil, F-94010, France.
Charles LaidiCEA, Université Paris-Saclay, Neurospin, Gif-sur-Yvette, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by social atypicalities and repetitive behaviors. Growing evidence suggests that alterations in brain networks may contribute to ASD symptoms. The cerebellum, with its widespread connections to the cortex, has emerged as a potential key player in ASD. Non-invasive neuromodulation techniques, such as transcranial direct current stimulation (tDCS) or repetitive transcranial magnetic stimulation (rTMS) offer a promising avenue for modulating brain activity and potentially alleviating ASD symptoms. In addition, preclinical studies in rodents further emphasize the therapeutic effect of cerebellar stimulation to target autism-related symptoms. This article reviews both clinical and preclinical studies aiming to modulate cerebellar circuits to improve symptoms of ASD. We found ten relevant studies assessing the effect of cerebellar neuromodulation in human and preclinical models. Posterior cerebellar tDCS represented the most frequent neuromodulation method and suggested that cerebellar tDCS can lead to improvements in symptoms of ASD and restore cerebellar connectivity in individuals with ASD. In neurotypical participants, there is evidence that cerebellar tDCS can enhance social cognitive abilities. These results are in line with preclinical studies, suggesting that chemogenetic stimulation can modulate cerebellar circuits involved in ASD and improve related behaviors. Further research is needed to establish standardized protocols, assess long-term effects, and investigate the underlying mechanisms of cerebellar stimulation. We examine research questions that need to be addressed before launching large scale randomized clinical trials.

Indexed as

Autism Spectrum DisorderCerebellumSocial CognitionTranscranial Direct Current StimulationAnimalsHumansTranscranial Magnetic StimulationAutismCerebellumSocial cognitionTranscranial direct current stimulationTranscranial magnetic stimulation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.